Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 38

    1.

    Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival.

    Bogunovic D, O'Neill DW, Belitskaya-Levy I, Vacic V, Yu YL, Adams S, Darvishian F, Berman R, Shapiro R, Pavlick AC, Lonardi S, Zavadil J, Osman I, Bhardwaj N.

    Proc Natl Acad Sci U S A. 2009 Nov 13. [Epub ahead of print]PMID: 19915147 [PubMed - as supplied by publisher]Related articles

    2.

    Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.

    Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, Sjolund A, Rimm DL, Wong H, Rodriguez A, Herschkowitz JI, Fan C, Zhang X, He X, Pavlick A, Gutierrez MC, Renshaw L, Larionov AA, Faratian D, Hilsenbeck SG, Perou CM, Lewis MT, Rosen JM, Chang JC.

    Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13820-5. Epub 2009 Aug 3.PMID: 19666588 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma.

    Eager RM, Cunningham CC, Senzer NN, Stephenson J Jr, Anthony SP, O'Day SJ, Frenette G, Pavlick AC, Jones B, Uprichard M, Nemunaitis J.

    BMC Cancer. 2009 Jul 30;9:263.PMID: 19643020 [PubMed - in process]Related articlesFree article

    4.

    Novel therapeutics for melanoma.

    Seetharamu N, Ott PA, Pavlick AC.

    Expert Rev Anticancer Ther. 2009 Jun;9(6):839-49. Review.PMID: 19496721 [PubMed - indexed for MEDLINE]Related articles

    5.

    Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma.

    Ott PA, Chang JL, Oratz R, Jones A, Farrell K, Muggia F, Pavlick AC.

    Chemotherapy. 2009;55(4):221-7. Epub 2009 May 19.PMID: 19451711 [PubMed - indexed for MEDLINE]Related articles

    6.

    Phosphorylated 4E-BP1 is associated with poor survival in melanoma.

    O'Reilly KE, Warycha M, Davies MA, Rodrik V, Zhou XK, Yee H, Polsky D, Pavlick AC, Rosen N, Bhardwaj N, Mills G, Osman I.

    Clin Cancer Res. 2009 Apr 15;15(8):2872-8. Epub 2009 Mar 31.PMID: 19336517 [PubMed - indexed for MEDLINE]Related articles

    7.

    Association of MDM2 SNP309, age of onset, and gender in cutaneous melanoma.

    Firoz EF, Warycha M, Zakrzewski J, Pollens D, Wang G, Shapiro R, Berman R, Pavlick A, Manga P, Ostrer H, Celebi JT, Kamino H, Darvishian F, Rolnitzky L, Goldberg JD, Osman I, Polsky D.

    Clin Cancer Res. 2009 Apr 1;15(7):2573-80. Epub 2009 Mar 24.PMID: 19318491 [PubMed - indexed for MEDLINE]Related articles

    8.

    Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors.

    Pavlick AC, Wu J, Roberts J, Rosenthal MA, Hamilton A, Wadler S, Farrell K, Carr M, Fry D, Murgo AJ, Oratz R, Hochster H, Liebes L, Muggia F.

    Cancer Chemother Pharmacol. 2009 Sep;64(4):803-10. Epub 2009 Feb 17.PMID: 19221754 [PubMed - indexed for MEDLINE]Related articles

    9.

    A phase 2, randomized study of SB-485232, rhIL-18, in patients with previously untreated metastatic melanoma.

    Tarhini AA, Millward M, Mainwaring P, Kefford R, Logan T, Pavlick A, Kathman SJ, Laubscher KH, Dar MM, Kirkwood JM.

    Cancer. 2009 Feb 15;115(4):859-68.PMID: 19140204 [PubMed - indexed for MEDLINE]Related articles

    10.

    Meta-analysis of sentinel lymph node positivity in thin melanoma (<or=1 mm).

    Warycha MA, Zakrzewski J, Ni Q, Shapiro RL, Berman RS, Pavlick AC, Polsky D, Mazumdar M, Osman I.

    Cancer. 2009 Feb 15;115(4):869-79.PMID: 19117354 [PubMed - indexed for MEDLINE]Related articles

    11.

    Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patients.

    Yu JZ, Warycha MA, Christos PJ, Darvishian F, Yee H, Kaminio H, Berman RS, Shapiro RL, Buckley MT, Liebes LF, Pavlick AC, Polsky D, Brooks PC, Osman I.

    J Transl Med. 2008 Nov 24;6:70.PMID: 19025658 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Type 2 Bias of T cells expanded from the blood of melanoma patients switched to type 1 by IL-12p70 mRNA-transfected dendritic cells.

    Minkis K, Kavanagh DG, Alter G, Bogunovic D, O'Neill D, Adams S, Pavlick A, Walker BD, Brockman MA, Gandhi RT, Bhardwaj N.

    Cancer Res. 2008 Nov 15;68(22):9441-50.PMID: 19010919 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Changes in the presentation of nodular and superficial spreading melanomas over 35 years.

    Warycha MA, Christos PJ, Mazumdar M, Darvishian F, Shapiro RL, Berman RS, Pavlick AC, Kopf AW, Polsky D, Osman I.

    Cancer. 2008 Dec 15;113(12):3341-8.PMID: 18988292 [PubMed - indexed for MEDLINE]Related articles

    14.

    Shedding of distinct cryptic collagen epitope (HU177) in sera of melanoma patients.

    Ng B, Zakrzewski J, Warycha M, Christos PJ, Bajorin DF, Shapiro RL, Berman RS, Pavlick AC, Polsky D, Mazumdar M, Montgomery A, Liebes L, Brooks PC, Osman I.

    Clin Cancer Res. 2008 Oct 1;14(19):6253-8.PMID: 18829505 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant.

    Adams S, O'Neill DW, Nonaka D, Hardin E, Chiriboga L, Siu K, Cruz CM, Angiulli A, Angiulli F, Ritter E, Holman RM, Shapiro RL, Berman RS, Berner N, Shao Y, Manches O, Pan L, Venhaus RR, Hoffman EW, Jungbluth A, Gnjatic S, Old L, Pavlick AC, Bhardwaj N.

    J Immunol. 2008 Jul 1;181(1):776-84.PMID: 18566444 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.

    Li X, Lewis MT, Huang J, Gutierrez C, Osborne CK, Wu MF, Hilsenbeck SG, Pavlick A, Zhang X, Chamness GC, Wong H, Rosen J, Chang JC.

    J Natl Cancer Inst. 2008 May 7;100(9):672-9. Epub 2008 Apr 29.PMID: 18445819 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of renal dysfunction: a study by the National Cancer Institute Organ Dysfunction Working Group.

    Gibbons J, Egorin MJ, Ramanathan RK, Fu P, Mulkerin DL, Shibata S, Takimoto CH, Mani S, LoRusso PA, Grem JL, Pavlick A, Lenz HJ, Flick SM, Reynolds S, Lagattuta TF, Parise RA, Wang Y, Murgo AJ, Ivy SP, Remick SC; National Cancer Institute Organ Dysfunction Working Group.

    J Clin Oncol. 2008 Feb 1;26(4):570-6.PMID: 18235116 [PubMed - indexed for MEDLINE]Related articles

    18.

    Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)--correlation with prognostic factors.

    Velazquez EF, Jungbluth AA, Yancovitz M, Gnjatic S, Adams S, O'Neill D, Zavilevich K, Albukh T, Christos P, Mazumdar M, Pavlick A, Polsky D, Shapiro R, Berman R, Spira J, Busam K, Osman I, Bhardwaj N.

    Cancer Immun. 2007 Jul 12;7:11.PMID: 17625806 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Role of radiologic imaging at the time of initial diagnosis of stage T1b-T3b melanoma.

    Yancovitz M, Finelt N, Warycha MA, Christos PJ, Mazumdar M, Shapiro RL, Pavlick AC, Osman I, Polsky D, Berman RS.

    Cancer. 2007 Sep 1;110(5):1107-14.PMID: 17620286 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming.

    Valmori D, Souleimanian NE, Tosello V, Bhardwaj N, Adams S, O'Neill D, Pavlick A, Escalon JB, Cruz CM, Angiulli A, Angiulli F, Mears G, Vogel SM, Pan L, Jungbluth AA, Hoffmann EW, Venhaus R, Ritter G, Old LJ, Ayyoub M.

    Proc Natl Acad Sci U S A. 2007 May 22;104(21):8947-52. Epub 2007 May 15.PMID: 17517626 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Detection of mutant BRAF alleles in the plasma of patients with metastatic melanoma.

    Yancovitz M, Yoon J, Mikhail M, Gai W, Shapiro RL, Berman RS, Pavlick AC, Chapman PB, Osman I, Polsky D.

    J Mol Diagn. 2007 Apr;9(2):178-83.PMID: 17384209 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma.

    Velazquez EF, Yancovitz M, Pavlick A, Berman R, Shapiro R, Bogunovic D, O'Neill D, Yu YL, Spira J, Christos PJ, Zhou XK, Mazumdar M, Nanus DM, Liebes L, Bhardwaj N, Polsky D, Osman I.

    J Transl Med. 2007 Jan 5;5:2.PMID: 17207277 [PubMed - in process]Related articlesFree article

    23.

    Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.

    Bedikian AY, Millward M, Pehamberger H, Conry R, Gore M, Trefzer U, Pavlick AC, DeConti R, Hersh EM, Hersey P, Kirkwood JM, Haluska FG; Oblimersen Melanoma Study Group.

    J Clin Oncol. 2006 Oct 10;24(29):4738-45. Epub 2006 Sep 11.PMID: 16966688 [PubMed - indexed for MEDLINE]Related articles

    24.

    Whole body PET/CT for initial staging of choroidal melanoma.

    Finger PT, Kurli M, Reddy S, Tena LB, Pavlick AC.

    Br J Ophthalmol. 2005 Oct;89(10):1270-4.PMID: 16170114 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Proteasome inhibition with bortezomib (PS-341): a phase I study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycle.

    Hamilton AL, Eder JP, Pavlick AC, Clark JW, Liebes L, Garcia-Carbonero R, Chachoua A, Ryan DP, Soma V, Farrell K, Kinchla N, Boyden J, Yee H, Zeleniuch-Jacquotte A, Wright J, Elliott P, Adams J, Muggia FM.

    J Clin Oncol. 2005 Sep 1;23(25):6107-16.PMID: 16135477 [PubMed - indexed for MEDLINE]Related articles

    26.

    Non-Hodgkin's lymphoma presenting as a breast mass in patients with HIV infection: a report of three cases.

    Chanan-Khan A, Holkova B, Goldenberg AS, Pavlick A, Demopoulos R, Takeshita K.

    Leuk Lymphoma. 2005 Aug;46(8):1189-93.PMID: 16085561 [PubMed - indexed for MEDLINE]Related articles

    27.

    PTEN expression in melanoma: relationship with patient survival, Bcl-2 expression, and proliferation.

    Mikhail M, Velazquez E, Shapiro R, Berman R, Pavlick A, Sorhaindo L, Spira J, Mir C, Panageas KS, Polsky D, Osman I.

    Clin Cancer Res. 2005 Jul 15;11(14):5153-7.PMID: 16033830 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.

    Kurli M, Reddy S, Tena LB, Pavlick AC, Finger PT.

    Am J Ophthalmol. 2005 Aug;140(2):193-9.PMID: 15992753 [PubMed - indexed for MEDLINE]Related articles

    29.

    Whole body PET/CT imaging for detection of metastatic choroidal melanoma.

    Finger PT, Kurli M, Wesley P, Tena L, Kerr KR, Pavlick A.

    Br J Ophthalmol. 2004 Aug;88(8):1095-7. No abstract available. PMID: 15258035 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    A phase I and pharmacokinetic study of docetaxel combined with Doxil (pegylated liposomal doxorubicin) without and with granulocyte colony stimulating factor.

    Pavlick AC, Chodkiewicz C, Liebes L, Hamilton A, Wasserheit C, Hochster H, Speyer J, Phillips Z, Downey A, Sorich J, Muggia F.

    Anticancer Drugs. 2004 Feb;15(2):119-25.PMID: 15075667 [PubMed - indexed for MEDLINE]Related articles

    31.

    Novel therapeutic agents under investigation for malignant melanoma.

    Pavlick AC, Adams S, Fink MA, Bailes A.

    Expert Opin Investig Drugs. 2003 Sep;12(9):1545-58. Review.PMID: 12943498 [PubMed - indexed for MEDLINE]Related articles

    32.

    Treatment of sarcomas: thinking out-of-the-box.

    Muggia FM, Pavlick A.

    Cancer Invest. 2003 Apr;21(2):321-2. No abstract available. PMID: 12743996 [PubMed - indexed for MEDLINE]Related articles

    33.

    Phase I study of amifostine as a cytoprotector of the gemcitabine/cisplatin combination in patients with advanced solid malignancies.

    Haigentz M Jr, Kim M, Sorich J, Lee J, Hochster H, Macapinlac M, Mirchandani D, Sewak S, Pavlick A, Volm M, Hamilton A, Muggia FM.

    Anticancer Drugs. 2003 Apr;14(4):321-6.PMID: 12679737 [PubMed - indexed for MEDLINE]Related articles

    34.

    Phase I/II trial of accutane as a potentiator of carboplatin and paclitaxel in squamous cell carcinomas.

    Wieder R, Pavlick AC, Bryan M, Hameed M, Baredes S, Pliner L, Saunders T, Korah R.

    Am J Clin Oncol. 2002 Oct;25(5):447-50.PMID: 12393981 [PubMed - indexed for MEDLINE]Related articles

    35.

    Chemotherapy approaches to melanoma.

    Pavlick AC.

    Dermatol Clin. 2002 Oct;20(4):709-12. Review.PMID: 12380057 [PubMed - indexed for MEDLINE]Related articles

    36.

    Ewing sarcoma in an octogenarian: a case report.

    Levine RG, Bono CM, Hameed M, Blacksin M, Pavlick AC, Cathcart C, Benevenia J.

    J Bone Joint Surg Am. 2002 Mar;84-A(3):445-8. No abstract available. PMID: 11886917 [PubMed - indexed for MEDLINE]Related articles

    37.

    Immunoproliferative small intestinal disease: case report and literature review.

    Trotman BW, Pavlick AC, Igwegbe IC, Goldstein MM.

    J Assoc Acad Minor Phys. 1999;10(4):88-93. Review.PMID: 10826015 [PubMed - indexed for MEDLINE]Related articles

    38.

    Endoscopic ultrasound in the evaluation of gastric small lymphocytic mucosa-associated lymphoid tumors.

    Pavlick AC, Gerdes H, Portlock CS.

    J Clin Oncol. 1997 May;15(5):1761-6.PMID: 9164183 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...